The present study aimed at evaluating the acute effect of increasing doses of octreotide (OCT), a long-acting somatostatin analogue, on glucose tolerance and insulin secretion
Thirty patients affected by insulin-dependent diabetes mellitus, without overt diabetic nephropathy,...
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked t...
It has recently been demonstrated in various clinical experiments that native somatostatin and its l...
The present study aimed at evaluating the acute effect of increasing doses of octreotide (OCT), a lo...
The effects on insulin secretion and on the glycaemic and androgen status before and after short-ter...
1. Exogenous somatostatin inhibits glucagon secretion and prevents ketoacidosis in diabetic patients...
Octreotide is a synthetic somatostatin analogue with similar but more prolonged pharmacological effe...
Summary: The role of somatostatin analogues in the medical management of insulinomas is unclear. We ...
Objective: In this study the effect of high dose octreotide LAR on glucose metabolism in patients wi...
The inhibitory effect of the somatostatin analogue octreotide on the secretion of insulin could be u...
Our aim was to clarify the effect of a somatostatin analogue (octreotide) on glucose flux in conscio...
The effects of conventional somatostatin analog (SSA) regimens on glucose homeostasis seem to have m...
OBJECTIVE: In this study, the effect of high-dose octreotide LAR on glucose metabolism in patients w...
Thirty patients affected by insulin-dependent diabetes mellitus, without overt diabetic nephropathy,...
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked t...
It has recently been demonstrated in various clinical experiments that native somatostatin and its l...
The present study aimed at evaluating the acute effect of increasing doses of octreotide (OCT), a lo...
The effects on insulin secretion and on the glycaemic and androgen status before and after short-ter...
1. Exogenous somatostatin inhibits glucagon secretion and prevents ketoacidosis in diabetic patients...
Octreotide is a synthetic somatostatin analogue with similar but more prolonged pharmacological effe...
Summary: The role of somatostatin analogues in the medical management of insulinomas is unclear. We ...
Objective: In this study the effect of high dose octreotide LAR on glucose metabolism in patients wi...
The inhibitory effect of the somatostatin analogue octreotide on the secretion of insulin could be u...
Our aim was to clarify the effect of a somatostatin analogue (octreotide) on glucose flux in conscio...
The effects of conventional somatostatin analog (SSA) regimens on glucose homeostasis seem to have m...
OBJECTIVE: In this study, the effect of high-dose octreotide LAR on glucose metabolism in patients w...
Thirty patients affected by insulin-dependent diabetes mellitus, without overt diabetic nephropathy,...
BACKGROUND:Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked t...
It has recently been demonstrated in various clinical experiments that native somatostatin and its l...
Add to ORKG